Holen Sie sich die Stockscreener-App
4.245
0.98%
0.005
Handel nachbörslich:
4.24
-0.005
-0.12%
Schlusskurs vom Vortag:
$4.24
Offen:
$4.29
24-Stunden-Volumen:
5.30M
Relative Volume:
1.23
Marktkapitalisierung:
$1.51B
Einnahmen:
$9.68M
Nettoeinkommen (Verlust:
$-250.64M
KGV:
-3.0326
EPS:
-1.3998
Netto-Cashflow:
$-89.83M
1W Leistung:
+2.92%
1M Leistung:
+3.67%
6M Leistung:
+14.48%
1J Leistung:
+212.52%
1-Tages-Spanne:
$4.14
$4.368
1-Wochen-Bereich:
$4.12
$4.368
52-Wochen-Spanne:
$1.28
$5.465
Precigen Inc Stock (PGEN) Company Profile
Firmenname
Precigen Inc
Sektor
Branche
Telefon
301-556-9900
Adresse
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
4.23 | 1.51B | 9.68M | -250.64M | -89.83M | -1.3998 |
VRTX
Vertex Pharmaceuticals Inc
|
436.05 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.42 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.61 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.35 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-15 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-03-22 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-05-23 | Eingeleitet | JP Morgan | Neutral |
| 2022-11-18 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-02-25 | Eingeleitet | Stifel | Buy |
| 2021-02-22 | Eingeleitet | Wells Fargo | Overweight |
| 2021-02-18 | Eingeleitet | B. Riley Securities | Buy |
| 2020-05-08 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Precigen Inc Aktie (PGEN) Neueste Nachrichten
Spotlight On 3 Growth Companies With Strong Insider Stakes - simplywall.st
Precigen CEO set for J.P. Morgan and Goldman Sachs healthcare fireside chats - Stock Titan
Precigen’s lead cancer therapy is fueling a massive stock rally — here’s what Wall Street sees next - MSN
What Precigen (PGEN)'s PAPZIMEOS-Fueled Q1 Revenue Surge Means For Shareholders - simplywall.st
Precigen (PGEN): The Best Penny Stock to Buy for Long Term - Insider Monkey
PGEN Stock Price, Quote & Chart | PRECIGEN INC (NASDAQ:PGEN) - ChartMill
Precigen Q1 earnings call highlights - MSN
Precigen: Why I Am More Cautious After The Q1 Beat (Downgrade) (NASDAQ:PGEN) - Seeking Alpha
5 Best Penny Stocks to Buy for Long Term - Insider Monkey
Precigen, Inc. (PGEN) Q1 2026 Earnings Call Transcript - Intellectia AI
PGEN - Intellectia AI
Precigen’s PAPZIMEOS Launch Drives Surging Q1 Revenue - TipRanks
How Surging PAPZIMEOS Revenue And Narrower Losses At Precigen (PGEN) Have Changed Its Investment Story - Sahm
Equities Analysts Set Expectations for Precigen Q3 Earnings - MarketBeat
Precigen Q1 earnings preview - MSN
Earnings Beat: Precigen, Inc. (NASDAQ:PGEN) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Yahoo Finance
Point72 (PGEN) reports 6.74M shares, 1.9% stake as of Mar 31, 2026 - Stock Titan
Precigen, Inc. (NASDAQ:PGEN) Q1 2026 Earnings Call Transcript - Insider Monkey
Precigen (PGEN) Shares Surge After Strong Q1 2026 Earnings Repor - GuruFocus
Precigen (PGEN) Reports Strong Q1 Earnings, Shares Surge Nearly 18% - GuruFocus
Earnings call transcript: Precigen beats Q1 2026 forecasts, stock surges - Investing.com UK
Earnings call transcript: Precigen beats Q1 2026 forecasts, stock surges By Investing.com - Investing.com Australia
Precigen Earnings Call Highlights PAPZIMEOS Launch Surge - TipRanks
PGEN Rated Buy by HC Wainwright & Co. -- Price Target Raised to $11.00 - GuruFocus
Precigen stock jumps after Q1 2026 beat (PGEN:NASDAQ) - Seeking Alpha
Precigen Stock Climbs After Strong 1Q for Papzimeos Sales - Moomoo
PGEN Maintained by Citizens -- Price Target Raised to $11.00 - GuruFocus
Precigen: Full Commercial Validation And Room To Run (NASDAQ:PGEN) - Seeking Alpha
Precigen (PGEN) Surges 27.6% in Premarket Trading - GuruFocus
This Biotech Has Soared Nearly 200% In A Year — Now Analysts See More Upside Ahead - Stocktwits
H.C. Wainwright raises Precigen stock price target on strong Papzimeos sales - Investing.com Nigeria
Precigen, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Precigen Stock Jumps as Papzimeos Sales Change the Story for PGEN Investors - TechStock²
Precigen price target raised to $11 from $10 at H.C. Wainwright - TipRanks
Citizens raises Precigen stock price target on strong launch By Investing.com - Investing.com Nigeria
H.C. Wainwright raises Precigen stock price target on strong Papzimeos sales By Investing.com - Investing.com South Africa
Precigen price target raised to $11 from $9 at Citizens - TipRanks
Why is Precigen stock surging today? By Investing.com - Investing.com Canada
Finanzdaten der Precigen Inc-Aktie (PGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.49%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):